GLP-1 Telehealth in Wisconsin: Provider Options, Cost & Laws 2026

Introduction

Wisconsin residents can get semaglutide and tirzepatide through telehealth in 2026 under Wis. Stat. 448 and Med 24 rules from the Medical Examining Board. The state permits first-visit prescribing of non-controlled medications after a synchronous audio-video encounter, with informed consent and identity verification documented in the chart.

Wisconsin has roughly 1.7 million adults with BMI 30+ per the 2023 BRFSS, with higher rates in the north and lower rates in Dane and Waukesha counties. The state joined the Interstate Medical Licensure Compact in 2017, feeding a deep multistate clinician pool serving Milwaukee, Madison, Green Bay, and the Northwoods.

This guide covers what is legal under Medical Examining Board rules, what Anthem Blue Cross Blue Shield Wisconsin, Quartz, and Security Health Plan cover, what compounded options cost after the FDA shortage delisting in early 2025, and how patients in places like Hayward, Eagle River, and Prairie du Chien get reliable cold-chain delivery.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Is GLP-1 Telehealth Legal in Wisconsin?

Yes. Wisconsin law permits telehealth prescribing of non-controlled medications, including all GLP-1 receptor agonists, after a real-time audio-video visit with a Wisconsin-licensed clinician. The framework sits in Wis. Stat. 448 and Med 24 from the Medical Examining Board.

Quick Answer: Wisconsin permits first-visit GLP-1 prescribing via telehealth under Wis. Stat. 448

Wisconsin is a full IMLC compact state, which gives out-of-state physicians an expedited path to Wisconsin licensure. The result is one of the deepest multistate telehealth clinician pools in the Upper Midwest.

A prior in-person relationship is not required. The first visit can run entirely over video. Wisconsin does require documented informed consent for telehealth and identity verification at the same standard as in-person care.

What Does GLP-1 Telehealth Cost in Wisconsin?

Cash prices for compounded semaglutide in Wisconsin in 2026 run $199 to $349 per month, with tirzepatide between $349 and $549. Brand Wegovy® lists at $1,349.02 per month and Zepbound® at $1,086.37 per month before any savings program.

LillyDirect offers Zepbound vials at $349 for 2.5 mg and up to $649 for higher doses through self-pay. NovoCare offers Wegovy at around $499 monthly for some uninsured patients, with eligibility rules that exclude Medicare and active commercial coverage. Wisconsin patients see the same direct-pay pricing as the rest of the country.

Telehealth platform fees typically bundle medication, supplies, and clinician visits into a flat monthly price. Milwaukee, Madison, Green Bay, Appleton, and Kenosha see identical pricing to Hayward, Eagle River, or Prairie du Chien because medication ships from the same partner pharmacies.

Which Insurance Plans Cover GLP-1s in Wisconsin?

Anthem Blue Cross Blue Shield Wisconsin, UnitedHealthcare, Quartz Health, Security Health Plan, and Aetna lead the commercial market. Wisconsin’s commercial landscape is unusually fragmented because of strong regional health system plans like Aurora and Marshfield. All carriers require prior authorization for brand GLP-1s and apply step therapy.

Anthem covers Wegovy and Zepbound for obesity when BMI is 30+, or 27+ with at least one comorbidity. The PA form requires documentation of three to six months of lifestyle intervention with weight or A1c data. Continued coverage past month six often requires 5% weight loss. Quartz and Security Health Plan apply similar criteria.

BadgerCare Plus (Wisconsin Medicaid) covers Ozempic® and Mounjaro® for type 2 diabetes but does not cover GLP-1s for obesity. Medicare Part D in Wisconsin also does not cover anti-obesity drugs despite the SELECT trial (Lincoff et al. 2023 NEJM) showing 20% MACE reduction with semaglutide.

What Is the Difference Between Compounded and Brand GLP-1s?

Brand-name Wegovy, Ozempic, and Rybelsus® are semaglutide manufactured by Novo Nordisk under FDA approval. Mounjaro and Zepbound are tirzepatide from Eli Lilly. Compounded versions use the same active pharmaceutical ingredient prepared by state-licensed 503A or 503B compounding pharmacies, usually combined with a vitamin to create a non-identical formulation.

The FDA removed semaglutide from its shortage list on February 21, 2025, and tirzepatide on December 19, 2024. Mass compounding of identical copies is no longer permitted. Compounders shifted to combination formulations like semaglutide with B12 or pyridoxine, which remain legal under section 503A when prescribed for an individual patient with documented medical need.

Wisconsin has two FDA-registered 503B outsourcing facilities. National telehealth platforms typically ship to Wisconsin from 503Bs in Illinois, Minnesota, or further away to optimize routing.

How Do You Get a GLP-1 Prescription in Wisconsin Through Telehealth?

Patients complete an intake form, submit recent biometrics, and book a video visit with a Wisconsin-licensed clinician. After the visit, the prescription ships from a partner pharmacy within three to five business days.

The TrimRx free assessment quiz takes about eight minutes. It screens for personal or family history of medullary thyroid carcinoma, MEN-2, pancreatitis, severe gastroparesis, pregnancy, and other contraindications. A clinician reviews the intake and runs the live video visit before writing any prescription.

Milwaukee, Madison, Green Bay, Appleton, and Kenosha typically see two-day delivery. Eau Claire, Wausau, and La Crosse see two to three days. The Northwoods and Bayfield/Iron/Vilas counties can see four to five days, especially in winter, though cold-chain packaging stays viable 72-96 hours.

Key Takeaway: Anthem and Quartz cover Wegovy/Zepbound with BMI 30+ or 27+ with comorbidity, PA required

What Are the Medical Eligibility Criteria?

Clinical eligibility follows FDA labeling for Wegovy and Zepbound: BMI 30+ or BMI 27+ with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidemia, OSA, or cardiovascular disease. Most platforms apply the same thresholds for compounded options.

Contraindications include personal or family history of medullary thyroid carcinoma, MEN-2, prior severe hypersensitivity to GLP-1s, history of pancreatitis, severe gastroparesis, and pregnancy or breastfeeding. Severe renal impairment requires dose adjustment per SUSTAIN-FORTE data.

Wisconsin telehealth platforms generally set a minimum age of 18 even though the FDA approved tirzepatide for adolescents 12+ in late 2024 based on SURMOUNT-Pediatric data. Pediatric obesity care typically routes through Children’s Wisconsin in Milwaukee or AFCH in Madison.

What Weight Loss Results Can Wisconsin Patients Expect?

Trial data sets the ceiling. STEP 1 (Wilding et al. 2021 NEJM) showed 14.9% mean weight loss at 68 weeks with 2.4 mg semaglutide. SURMOUNT-1 (Jastreboff et al. 2022 NEJM) showed 20.9% with 15 mg tirzepatide at 72 weeks. SURMOUNT-3 added intensive lifestyle and reached 26.6%.

Real-world Wisconsin telehealth cohorts at six months typically see 8-12% loss on compounded semaglutide and 11-15% on tirzepatide. Adherence at one year averages 55-65% per 2024-2025 claims database studies.

Cardiovascular and metabolic outcomes matter beyond weight. SELECT showed 20% MACE reduction. FLOW (Perkovic et al. 2024 NEJM) showed 24% reduction in kidney failure and CV death. SURMOUNT-OSA led the FDA to approve tirzepatide for obstructive sleep apnea in December 2024.

What Side Effects Should Wisconsin Patients Prepare For?

Nausea, vomiting, constipation, and diarrhea hit 40-50% of patients during dose escalation per STEP and SURMOUNT safety profiles. Most cases resolve within two to four weeks at each new dose step.

Less common but more serious risks include pancreatitis (0.2-0.3% per year), gallbladder disease (1-2% per year), and acute kidney injury from severe dehydration. The FDA added gastroparesis warnings to semaglutide and tirzepatide labels in 2023.

Wisconsin winters create cold-chain logistics issues that summer doesn’t. Cold packs can freeze the medication if a package sits outside in single-digit temperatures. Patients in the Northwoods should bring shipments inside promptly. Platform-side triage often prevents unnecessary ER visits for routine GI side effects.

How Does Wisconsin Compare to Other States?

Wisconsin’s IMLC membership and friendly telehealth statute put it among the more accessible states for GLP-1 telehealth. Minnesota next door has similar rules and broader Medicaid GLP-1 coverage. Illinois has higher 503B pharmacy density.

The fragmented commercial market in Wisconsin produces more variable PA outcomes than states with one or two dominant carriers. Aurora-affiliated plans, Marshfield Clinic, ThedaCare, and other regional plans each apply slightly different criteria. Average time from intake submission to first video visit on national platforms averaged 22 hours in Wisconsin as of Q4 2025.

A personalized treatment plan that factors in BadgerCare eligibility, Anthem vs. regional health system formulary differences, and winter shipping considerations often saves Wisconsin patients money over the first year.

Bottom line: STEP 1 trial (Wilding 2021 NEJM) showed 14.9% weight loss with semaglutide at 68 weeks

FAQ

Can I Get a GLP-1 Prescription in Wisconsin Without an In-person Visit?

Yes. Wisconsin allows first-visit prescribing through telehealth after a synchronous video visit with a Wisconsin-licensed clinician.

Does BadgerCare Plus Cover Wegovy?

No. BadgerCare Plus covers Ozempic and Mounjaro for type 2 diabetes only. It does not cover any GLP-1 for obesity.

How Long Does Shipping Take to the Northwoods?

Most Northwoods ZIP codes receive shipments within 4-5 business days. Cold-chain packaging keeps medication viable for 72-96 hours.

Is Compounded Semaglutide Legal in Wisconsin in 2026?

Yes, when it is a combination formulation prescribed for an individual patient by a licensed clinician and dispensed by a state-licensed 503A or 503B pharmacy.

Does Anthem Wisconsin Require a Six-month Diet History for GLP-1 Prior Auth?

Anthem generally requires three to six months of documented lifestyle intervention. Some self-insured employer plans extend that to twelve months.

Will Winter Cold Damage Shipped Medication in Wisconsin?

Cold-chain packaging is designed for refrigeration temperatures, but extreme freezing can damage GLP-1 medications. Bring shipments inside as soon as they arrive in winter.

Can I Switch From Wegovy to Compounded Semaglutide If My Insurance Drops Coverage?

Yes. A telehealth clinician can transition you between formulations at the equivalent maintenance dose.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.